Nakamura, K.; Akagi, S.; Ejiri, K.; Taya, S.; Saito, Y.; Kuroda, K.; Takaya, Y.; Toh, N.; Nakayama, R.; Katanosaka, Y.;
et al. Pathophysiology of Group 3 Pulmonary Hypertension Associated with Lung Diseases and/or Hypoxia. Int. J. Mol. Sci. 2025, 26, 835.
https://doi.org/10.3390/ijms26020835
AMA Style
Nakamura K, Akagi S, Ejiri K, Taya S, Saito Y, Kuroda K, Takaya Y, Toh N, Nakayama R, Katanosaka Y,
et al. Pathophysiology of Group 3 Pulmonary Hypertension Associated with Lung Diseases and/or Hypoxia. International Journal of Molecular Sciences. 2025; 26(2):835.
https://doi.org/10.3390/ijms26020835
Chicago/Turabian Style
Nakamura, Kazufumi, Satoshi Akagi, Kentaro Ejiri, Satoshi Taya, Yukihiro Saito, Kazuhiro Kuroda, Yoichi Takaya, Norihisa Toh, Rie Nakayama, Yuki Katanosaka,
and et al. 2025. "Pathophysiology of Group 3 Pulmonary Hypertension Associated with Lung Diseases and/or Hypoxia" International Journal of Molecular Sciences 26, no. 2: 835.
https://doi.org/10.3390/ijms26020835
APA Style
Nakamura, K., Akagi, S., Ejiri, K., Taya, S., Saito, Y., Kuroda, K., Takaya, Y., Toh, N., Nakayama, R., Katanosaka, Y., & Yuasa, S.
(2025). Pathophysiology of Group 3 Pulmonary Hypertension Associated with Lung Diseases and/or Hypoxia. International Journal of Molecular Sciences, 26(2), 835.
https://doi.org/10.3390/ijms26020835
